The market for GLP-1 medications is already huge, and is expected to explode. It was valued at about $52 billion in 2024; that’s predicted to rise to $187 billion by 2032, for compound annual growth …
This Healthcare Company Just Touched $1 Trillion in Market Cap. Should You Invest $1,000?
view original post